Home » Healthcare » Pharmaceuticals » Indonesia Gastrointestinal Products Market

Indonesia Gastrointestinal Products Market By Devices (Endoscopy Devices, Ablation Devices, Motility Testing Devices, Biopsy Devices, Stenting Devices); By Indications (Gastrointestinal Cancers, Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, Inflammatory Bowel Disease, Other Diseases); By End-User (Hospitals, Ambulatory Surgical Centers & Independent Surgical Centers, Clinics, Other End Users) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Indonesia Gastrointestinal Products Market Size 2023	USD 84.46 million
Indonesia Gastrointestinal Products Market, CAGR	5.51%
Indonesia Gastrointestinal Products Market Size 2032	USD 137.08 million

Market Overview

The Indonesia Gastrointestinal Products Market is projected to grow from USD 84.46 million in 2023 to USD 137.08 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.51%.

The growth of the Indonesia gastrointestinal products market is driven by several factors, including the increasing prevalence of gastrointestinal disorders, such as irritable bowel syndrome, acid reflux, and inflammatory bowel disease, due to changing lifestyles and dietary habits. Rising healthcare awareness and the expanding access to medical services in the country further fuel demand for these products. Additionally, the aging population is contributing to a higher incidence of digestive health issues, thereby propelling the market growth. The adoption of innovative treatments and the growing availability of over-the-counter (OTC) gastrointestinal medications are key trends enhancing market dynamics. Furthermore, advancements in pharmaceutical research, the introduction of more effective and specialized gastrointestinal products, and the rising trend of self-medication are expected to drive future growth. As the healthcare infrastructure improves, consumers are increasingly turning to gastrointestinal treatments to manage their health concerns effectively, propelling market expansion at a steady pace.

Indonesia’s gastrointestinal products market is characterized by regional variations, with key players focusing on expanding their presence across diverse islands like Java, Sumatra, Kalimantan, and Sulawesi. Java, being the economic hub, attracts the majority of healthcare investments, while Sumatra and Kalimantan are experiencing steady growth in gastrointestinal care due to improved healthcare access. Sulawesi, though a smaller market, is gradually expanding as healthcare infrastructure improves. Key players in this market include prominent global and regional companies such as Boston Scientific Corporation, Medtronic, Stryker, and Karl Storz, which are leading in the development and distribution of advanced gastrointestinal devices and treatments. Additionally, local players are also gaining ground, particularly in the distribution of basic gastrointestinal therapies and over-the-counter products. The competitive landscape is evolving, with both international and domestic companies vying for market share through product innovations and strategic partnerships.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The Indonesia gastrointestinal products market is valued at USD 84.46 million in 2023 and is projected to reach USD 137.08 million by 2032, growing at a CAGR of 5.51%.
Increasing prevalence of gastrointestinal disorders such as GERD, IBS, and IBD is a significant driver for market growth.
Rising adoption of advanced medical technologies, including endoscopy and motility testing devices, is boosting the market.
The shift toward minimally invasive procedures and the growing demand for diagnostic tools are notable market trends.
Stringent regulations and high costs of advanced devices are challenges for market players.
The market is experiencing strong competition, with key players like Boston Scientific, Medtronic, and Stryker leading in device innovation.
Regional growth is concentrated in Java, with emerging demand in Sumatra and Kalimantan as healthcare access improves.

Market Drivers

Increasing Prevalence of Gastrointestinal Disorders

The rising incidence of gastrointestinal disorders, such as acid reflux, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD), is a significant driver of the Indonesia gastrointestinal products market. Poor dietary habits, high-stress levels, and an increasingly sedentary lifestyle contribute to the growing prevalence of these conditions. For instance, a national survey highlighted that gastrointestinal diseases like gastroesophageal reflux disease (GERD) and IBD have seen a notable increase in recent years. As more individuals seek effective treatment options to manage symptoms, the demand for gastrointestinal products, including medications, supplements, and functional foods, continues to rise.

Growing Healthcare Awareness

Improved healthcare awareness among the Indonesian population is another key driver fueling the demand for gastrointestinal products. As people become more informed about digestive health and its impact on overall well-being, they are more likely to seek preventive measures and treatments for gastrointestinal issues. For instance, the implementation of the Jaminan Kesehatan Nasional (JKN) health insurance program has significantly increased public awareness and access to healthcare services. This has led to a rise in consumer demand for over-the-counter (OTC) products, probiotics, and specialized treatments, further contributing to market growth.

Expanding Access to Healthcare Services

The expansion of healthcare infrastructure in Indonesia has made gastrointestinal products more accessible to a wider population. Government initiatives aimed at improving healthcare delivery, along with increased private sector involvement, have made it easier for consumers to access medical treatments and medications for digestive health. This increased accessibility is driving the adoption of gastrointestinal products across urban and rural areas, ensuring a broader market reach.

Innovation in Gastrointestinal Treatments

Advancements in medical research and innovation in gastrointestinal treatments are propelling market growth in Indonesia. New drug formulations, better-targeted therapies, and the increasing availability of specialized gastrointestinal products have made it easier for consumers to manage digestive disorders effectively. The introduction of new delivery methods, such as liquid formulations, chewable tablets, and more potent over-the-counter medications, is meeting the growing demand for more convenient and effective solutions, thus supporting market expansion.

Market Trends

Shift Towards Preventive Healthcare

A notable trend in the Indonesia gastrointestinal products market is the growing focus on preventive healthcare. As consumers become more aware of the importance of maintaining digestive health, there is an increasing demand for products that promote gut health and prevent gastrointestinal issues. For instance, a survey by the Central Statistics Agency (BPS) indicated a significant rise in the consumption of probiotics and fiber supplements among health-conscious Indonesians. This shift toward proactive health management reflects a broader societal trend toward wellness and self-care, driving the growth of gastrointestinal products.

Rising Popularity of Over-the-Counter (OTC) Products

Over-the-counter (OTC) gastrointestinal products are experiencing heightened demand in Indonesia due to the growing trend of self-medication. Consumers are increasingly opting for OTC medications to manage mild to moderate gastrointestinal discomfort without the need for a prescription. This trend is fueled by the convenience and affordability of OTC products, which offer quick relief for common digestive issues such as indigestion, acid reflux, and bloating. As access to healthcare services continues to improve, this trend is expected to drive market growth further.

Integration of Digital Health Solutions

The integration of digital health solutions with gastrointestinal products is another emerging trend in Indonesia. Many companies are now offering digital platforms and mobile apps that help consumers track their digestive health, monitor symptoms, and receive personalized recommendations. These digital tools are enhancing the consumer experience by providing better access to information, enabling early detection of gastrointestinal issues, and offering tailored treatment plans. As digital health solutions gain traction, they are expected to complement traditional gastrointestinal products, further expanding the market.

Innovation in Product Offerings

Innovation in gastrointestinal product offerings is shaping market trends in Indonesia. Companies are continuously developing new formulations and delivery methods to meet the evolving needs of consumers. For example, there is a growing interest in natural and herbal gastrointestinal products that cater to consumers seeking alternatives to synthetic medications. Additionally, the development of targeted treatments for specific gastrointestinal conditions, such as probiotics for IBS or specialized enzymes for food intolerances, is driving product diversification, which in turn supports market growth.

Market Challenges Analysis

Regulatory Challenges and Product Approvals

One of the significant challenges facing the Indonesia gastrointestinal products market is the complex regulatory landscape. The approval process for new drugs and supplements can be lengthy and stringent, with manufacturers needing to comply with various health and safety regulations set by Indonesia’s National Agency of Drug and Food Control (BPOM). This process can delay product launches and increase the cost of bringing new products to market. Additionally, navigating the regulatory requirements for both prescription and over-the-counter (OTC) gastrointestinal products can be cumbersome, particularly for foreign manufacturers unfamiliar with local regulations, hindering their ability to expand in the market.

Price Sensitivity and Affordability

Price sensitivity among consumers in Indonesia poses another challenge for the gastrointestinal products market. While there is growing demand for effective treatments, many consumers remain cautious about spending on healthcare products due to financial constraints. For instance, a survey by the Indonesian Ministry of Health highlighted that a significant portion of the population prioritizes affordability when choosing healthcare products. The affordability of gastrointestinal products, especially those that are imported or newly launched, can limit their accessibility to a broader audience. As a result, companies need to find a balance between maintaining product quality and offering competitive pricing to cater to both lower and middle-income consumers. Without addressing affordability concerns, the market may face limitations in reaching its full growth potential.

Market Opportunities

Expanding Consumer Awareness and Demand for Preventive Products

The growing awareness of gastrointestinal health presents a significant opportunity for companies in the Indonesia gastrointestinal products market. As the population becomes more educated about the importance of digestive health and the role it plays in overall well-being, there is an increasing demand for preventive solutions. Probiotics, fiber supplements, and other functional foods designed to promote gut health are gaining popularity. This shift towards preventive care offers companies the chance to develop and market innovative products that cater to health-conscious consumers, helping to drive market growth. The trend towards wellness and self-care creates a strong foundation for new product lines and services targeting digestive health maintenance.

Growth in the Aging Population and Healthcare Access

Indonesia’s aging population also presents a significant market opportunity for gastrointestinal products. As the elderly population increases, so does the prevalence of age-related digestive issues, such as acid reflux, constipation, and inflammatory bowel disease (IBD). This demographic is more likely to seek effective treatments for managing gastrointestinal conditions, driving demand for both prescription medications and over-the-counter products. Additionally, the expansion of healthcare access in rural and underserved regions provides companies with an opportunity to reach a broader consumer base. By aligning with government health initiatives and enhancing distribution networks, businesses can tap into this underserved market, contributing to both social good and business growth.

Market Segmentation Analysis:

By Devices:

The Indonesia gastrointestinal products market is significantly segmented by devices used for diagnostic and therapeutic purposes. Endoscopy devices dominate this segment, widely used for visualizing the gastrointestinal tract and diagnosing conditions such as cancers and inflammatory diseases. Ablation devices, which use heat or cold to treat tumors or abnormal tissues, are also gaining traction in the market due to their effectiveness in treating gastrointestinal cancers. Motility testing devices, used to assess the movement of the digestive tract, are crucial for diagnosing disorders like gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS). Biopsy devices, essential for obtaining tissue samples for diagnosis, continue to play a vital role in detecting gastrointestinal cancers and other disorders. Stenting devices, used to relieve obstructions in the gastrointestinal tract, are essential in treating conditions such as esophageal cancer and strictures. The diversity of devices catering to different needs within gastrointestinal care offers significant growth opportunities in the Indonesian market.

By Indications:

The gastrointestinal products market in Indonesia is also segmented based on indications, including gastrointestinal cancers, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and other diseases. Gastrointestinal cancers represent a critical segment, with rising cases driving demand for diagnostic tools and therapeutic devices. GERD is a prevalent condition in Indonesia, fueling the demand for medications, devices, and treatment options aimed at alleviating acid reflux symptoms. IBS, characterized by abdominal discomfort and irregular bowel movements, is another key indication, prompting growth in both pharmaceutical treatments and diagnostic devices. IBD, including Crohn’s disease and ulcerative colitis, is gaining attention due to its chronic nature, leading to increasing demand for both medication and monitoring devices. The “Other Diseases” category encompasses a range of gastrointestinal disorders, creating a diverse demand for treatment options across various consumer segments.

Segments:

Based on Devices:

Endoscopy Devices
Ablation Devices
Motility Testing Devices
Biopsy Devices
Stenting Devices

Based on Indications:

Gastrointestinal Cancers
Gastroesophageal Reflux Disease
Irritable Bowel Syndrome
Inflammatory Bowel Disease
Other Diseases

Based on End-User:

Hospitals
Ambulatory Surgical Centers & Independent Surgical Centers
Clinics
Other End Users

Based on the Geography:

Java
Sumatra
Kalimantan
Sulawesi

Regional Analysis

Java

Java is the economic and population hub of Indonesia, contributing significantly to the demand for gastrointestinal products. With over 55% of the market share, Java’s demand is driven by its high population density, urbanization, and advanced healthcare infrastructure. Jakarta, the capital city, serves as the epicenter for healthcare innovations, attracting both local and international gastrointestinal product manufacturers. The increasing prevalence of lifestyle-related gastrointestinal disorders, such as acid reflux and irritable bowel syndrome (IBS), in urban centers is further fueling market growth. As a result, Java accounts for the highest consumption of both prescription medications and over-the-counter gastrointestinal products.

Sumatra

Sumatra, representing around 20% of the gastrointestinal products market, is witnessing steady growth due to improvements in healthcare access and increasing awareness of gastrointestinal health. As the second-largest island in Indonesia, Sumatra has a diverse population with varying healthcare needs. While urban centers like Medan drive demand for advanced diagnostic and therapeutic devices, rural areas are seeing a rise in basic gastrointestinal treatments. The growing incidence of diseases like gastroesophageal reflux disease (GERD) and inflammatory bowel disease (IBD) is prompting both government and private sector investments in healthcare services, contributing to the expansion of the gastrointestinal products market in the region.

Kalimantan and Sulawesi

Kalimantan and Sulawesi, with market shares of 15% and 10%, respectively, represent emerging markets in Indonesia. Kalimantan, rich in natural resources, has seen an increase in healthcare infrastructure, though it remains more focused on primary care compared to Java or Sumatra. The growing middle class and improving healthcare services are gradually driving demand for gastrointestinal products. In Sulawesi, where agriculture and fisheries dominate the economy, gastrointestinal disorders related to dietary habits are becoming more prevalent. While the market in these regions is smaller, both Kalimantan and Sulawesi present significant opportunities for manufacturers to tap into underserved populations by expanding healthcare access and offering affordable gastrointestinal treatments.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Boston Scientific Corporation
Ovesco Endoscopy AG
PENTAX Medical
Zhejiang Tiansong Medical Instrument Co
Medtronic
Stryker
Smith & Nephew
Karl Storz
Hoya
Company 10
Company 11
Company 12
Company 13
Company 14

Competitive Analysis

The competitive landscape of Indonesia’s gastrointestinal products market is marked by the presence of key global and regional players, including Boston Scientific, Medtronic, Stryker, Karl Storz, and Pentax Medical. Leading companies are investing heavily in research and development to offer advanced solutions such as endoscopy devices, biopsy tools, and ablation systems, which cater to the increasing demand for minimally invasive procedures. For instance, a report highlighted that companies like Boston Scientific have been focusing on developing innovative endoscopy devices to enhance diagnostic accuracy and patient outcomes. Companies are also focusing on improving the accuracy and efficiency of diagnostic tools, such as motility testing and stenting devices, to meet the growing healthcare needs. In addition to innovation, pricing strategies and distribution networks play a crucial role in maintaining a competitive edge, particularly in rural and underserved regions. The market is witnessing increased competition as companies aim to strengthen their foothold through strategic partnerships, acquisitions, and product diversification. With the growing awareness of gastrointestinal diseases and the rising demand for advanced treatment options, the competition among market players is expected to intensify in the coming years.

Recent Developments

In April 2023, Boston Scientific announced the launch of the EXALT Model B Single-use Bronchoscope, which expands its single-use endoscopy portfolio. This device is designed for diagnostic and therapeutic bronchoscopy procedures and offers high-resolution imaging and precise control.
In March 2023, Polifarma Spa expanded its gastrointestinal portfolio through a long-term distribution agreement with Devintec Pharma Sagl, a Lugano-based company known for pioneering substance-based medical devices and the Gelsectan brand.
In April 2023, Italian pharmaceutical innovator Azienda Farmaceutica Italiana partnered with TannerLAC, Inc. to distribute Hepilor, a medical device designed to protect the digestive system mucosa, throughout Latin America.
In May 2022, Dr. Reddy’s Laboratories Ltd. announced a partnership with South Korea’s HK inno.N Corporation to supply and commercialize HK inno.N’s patented novel molecule, Tegoprazan, for treating gastrointestinal diseases in India and six key emerging markets.
In March 2022, AbbVie Inc. received U.S. FDA approval for its novel drug, RINVOQ (upadacitinib), for the treatment of moderately to severely active ulcerative colitis.

Market Concentration & Characteristics

The market concentration of Indonesia’s gastrointestinal products is moderately fragmented, with a mix of both multinational corporations and local players. While global companies dominate the high-end device segment, particularly in endoscopy, biopsy, and ablation devices, regional players continue to hold a significant share by catering to the demand for cost-effective and basic diagnostic tools. The market characteristics are defined by the ongoing technological advancements, with a strong focus on minimally invasive procedures, which are increasingly preferred by both healthcare providers and patients due to their benefits, such as quicker recovery times and reduced risks. Additionally, there is a growing shift towards the adoption of diagnostic and therapeutic devices that offer higher accuracy and efficiency in detecting and treating gastrointestinal diseases. The market is characterized by a continuous push for innovation, with companies investing in research and development to enhance device performance and patient outcomes. Furthermore, the healthcare infrastructure in Indonesia, particularly in rural areas, presents both challenges and opportunities. While access to advanced gastrointestinal products is still limited in these regions, it creates significant potential for growth as the healthcare system improves and the demand for medical devices rises. Competitive strategies in this market include a mix of product differentiation, affordability, and expanding distribution networks to reach a broader customer base.

Report Coverage

The research report offers an in-depth analysis based on Devices, Indications, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The rise in disposable income and improving healthcare standards in Indonesia will contribute to higher demand for advanced gastrointestinal treatments.
Expanding healthcare facilities, especially in tier 2 and tier 3 cities, will further promote the uptake of gastrointestinal devices and treatments.
Increased investment in research and development will lead to more efficient and patient-friendly devices entering the market.
The growing trend of digital health solutions, such as telemedicine, will drive demand for remote diagnostic tools and monitoring devices.
The government’s focus on expanding insurance coverage for healthcare treatments will make gastrointestinal products more accessible to a larger population.
Strategic collaborations and partnerships between local players and international firms will enhance market penetration and innovation.
The rise in aging population, which is more susceptible to gastrointestinal diseases, will be a key driver for long-term market growth.
Companies will continue to focus on environmental sustainability, leading to the development of eco-friendly and reusable medical devices.
There will be a rise in awareness campaigns and preventive healthcare measures, fostering early detection and treatment of gastrointestinal issues.
The market will witness an increase in the number of specialized centers dedicated to treating gastrointestinal conditions, enhancing demand for high-quality medical devices.

CHAPTER NO. 1 : INTRODUCTION 20

1.1.1. Report Description 20

Purpose of the Report 20

USP & Key Offerings 20

1.1.2. Key Benefits for Stakeholders 20

1.1.3. Target Audience 21

1.1.4. Report Scope 21

CHAPTER NO. 2 : EXECUTIVE SUMMARY 22

2.1. GASTROINTESTINAL PRODUCTS Market Snapshot 22

2.1.1. Indonesia GASTROINTESTINAL PRODUCTS Market, 2018 – 2032 (USD Million) 23

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 24

3.1. Russia-Ukraine and Israel-Palestine War Impacts 24

CHAPTER NO. 4 : GASTROINTESTINAL PRODUCTS MARKET – INDUSTRY ANALYSIS 25

4.1. Introduction 25

4.2. Market Drivers 26

4.2.1. GI Disorders on a Rise 26

4.2.2. New and innovative technologies driving the market 27

4.3. Market Restraints 28

4.3.1. Stringent Regulations 28

4.4. Market Opportunities 29

4.4.1. Market Opportunity Analysis 29

4.5. Porter’s Five Forces Analysis 30

4.6. Value Chain Analysis 31

4.7. Buying Criteria 32

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 33

5.1. Import Analysis by Indonesia 33

5.1.1. Indonesia GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By Indonesia, 2018 – 2023 33

5.2. Export Analysis by Indonesia 34

5.2.1. Indonesia GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By Indonesia, 2018 – 2023 34

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 35

6.1. Demand Analysis by Indonesia 35

6.1.1. Indonesia GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By Indonesia, 2018 – 2023 35

6.2. Supply Analysis by Indonesia 36

6.2.1. Indonesia GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By Indonesia, 2018 – 2023 36

CHAPTER NO. 7 : PRODUCTION ANALYSIS 37

7.1. Production Analysis by Indonesia 37

7.1.1. Indonesia GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By Indonesia, 2018 – 2023 37

CHAPTER NO. 8 : PRICE ANALYSIS 38

8.1. Price Analysis by Devices 38

8.1.1. Indonesia GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 38

8.1.2. Indonesia Devices Market Price, By Devices, 2018 – 2023 38

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 39

9.1. Key Raw Materials and Suppliers 39

9.2. Key Raw Materials Price Trend 39

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 40

10.1. Manufacturing Cost Analysis 40

10.2. Manufacturing Process 40

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 41

11.1. Company Market Share Analysis – 2023 41

11.1.1. Indonesia GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Volume, 2023 41

11.1.2. Indonesia GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Revenue, 2023 42

11.1.3. Indonesia GASTROINTESTINAL PRODUCTS Market: Top 6 Company Market Share, by Revenue, 2023 42

11.1.4. Indonesia GASTROINTESTINAL PRODUCTS Market: Top 3 Company Market Share, by Revenue, 2023 43

11.2. Indonesia GASTROINTESTINAL PRODUCTS Market Company Volume Market Share, 2023 44

11.3. Indonesia GASTROINTESTINAL PRODUCTS Market Company Revenue Market Share, 2023 45

11.4. Company Assessment Metrics, 2023 46

11.4.1. Stars 46

11.4.2. Emerging Leaders 46

11.4.3. Pervasive Players 46

11.4.4. Participants 46

11.5. Start-ups /SMEs Assessment Metrics, 2023 46

11.5.1. Progressive Companies 46

11.5.2. Responsive Companies 46

11.5.3. Dynamic Companies 46

11.5.4. Starting Blocks 46

11.6. Strategic Developments 47

11.6.1. Acquisitions & Mergers 47

New Product Launch 47

Indonesia Expansion 47

11.7. Key Players Product Matrix 48

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 49

12.1. PESTEL 49

12.1.1. Political Factors 49

12.1.2. Economic Factors 49

12.1.3. Social Factors 49

12.1.4. Technological Factors 49

12.1.5. Environmental Factors 49

12.1.6. Legal Factors 49

12.2. Adjacent Market Analysis 49

CHAPTER NO. 13 : GASTROINTESTINAL PRODUCTS MARKET – BY DEVICES SEGMENT ANALYSIS 50

13.1. GASTROINTESTINAL PRODUCTS Market Overview, by Devices Segment 50

13.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 51

13.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Devices 52

13.1.3. Incremental Revenue Growth Opportunity, by Devices, 2024 – 2032 52

13.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 53

13.2. Endoscopy Devices 54

13.3. Ablation Devices 55

13.4. Motility Testing Devices 56

13.5. Biospy Devices 57

13.6. Stenting Devices 58

CHAPTER NO. 14 : GASTROINTESTINAL PRODUCTS MARKET – BY INDICATIONS SEGMENT ANALYSIS 59

14.1. GASTROINTESTINAL PRODUCTS Market Overview, by Indications Segment 59

14.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 60

14.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Indications 61

14.1.3. Incremental Revenue Growth Opportunity, by Indications, 2024 – 2032 61

14.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 62

14.2. Gastrointestinal Cancers 63

14.3. Gastroesophageal Reflux Disease 64

14.4. Irritable Bowl Syndrome 65

14.5. Inflammatory Bowel Disease 66

14.6. Other Disease 67

CHAPTER NO. 15 : GASTROINTESTINAL PRODUCTS MARKET – BY END-USER SEGMENT ANALYSIS 68

15.1. GASTROINTESTINAL PRODUCTS Market Overview, by End-user Segment 68

15.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 69

15.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By End-user 70

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 70

15.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 71

15.2. Hospital 72

15.3. Ambulatory Surgical Center & Independent Surgical Center 73

15.4. Clinics 74

15.5. Other End Users 75

CHAPTER NO. 16 : COMPANY PROFILES 76

16.1. Boston Scientific Corporation 76

16.1.1. Company Overview 76

16.1.2. Product Portfolio 76

16.1.3. Swot Analysis 76

16.1.4. Business Strategy 77

16.1.5. Financial Overview 77

16.2. Ovesco Endoscopy AG 78

16.3. PENTAX Medical 78

16.4. Zhejiang Tiansong Medical Instrument Co 78

16.5. Medtronic 78

16.6. Stryker 78

16.7. Smith & Nephew 78

16.8. Karl Storz 78

16.9. Hoya 78

16.10. Company 10 78

16.11. Company 11 78

16.12. Company 12 78

16.13. Company 13 78

16.14. Company 14 78

List of Figures

FIG NO. 1. Indonesia GASTROINTESTINAL PRODUCTS Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for Indonesia GASTROINTESTINAL PRODUCTS Market 29

FIG NO. 3. Value Chain Analysis for Indonesia GASTROINTESTINAL PRODUCTS Market 30

FIG NO. 4. Indonesia GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By Indonesia, 2018 – 2023 32

FIG NO. 5. Indonesia GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By Indonesia, 2018 – 2023 33

FIG NO. 6. Indonesia GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By Indonesia, 2018 – 2023 34

FIG NO. 7. Indonesia GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By Indonesia, 2018 – 2023 35

FIG NO. 8. Indonesia GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By Indonesia, 2018 – 2023 36

FIG NO. 9. Indonesia GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 37

FIG NO. 10. Raw Materials Price Trend Analysis, 2018 – 2023 38

FIG NO. 11. Manufacturing Cost Analysis 39

FIG NO. 12. Manufacturing Process 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. GASTROINTESTINAL PRODUCTS Market – Company Volume Market Share, 2023 43

FIG NO. 18. GASTROINTESTINAL PRODUCTS Market – Company Revenue Market Share, 2023 44

FIG NO. 19. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Devices 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Devices, 2024 – 2032 51

FIG NO. 22. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 52

FIG NO. 23. Indonesia GASTROINTESTINAL PRODUCTS Market for Endoscopy Devices, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. Indonesia GASTROINTESTINAL PRODUCTS Market for Ablation Devices, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. Indonesia GASTROINTESTINAL PRODUCTS Market for Motility Testing Devices, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. Indonesia GASTROINTESTINAL PRODUCTS Market for Biospy Devices, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. Indonesia GASTROINTESTINAL PRODUCTS Market for Stenting Devices, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Indications 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Indications, 2024 – 2032 60

FIG NO. 31. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 61

FIG NO. 32. Indonesia GASTROINTESTINAL PRODUCTS Market for Gastrointestinal Cancers, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. Indonesia GASTROINTESTINAL PRODUCTS Market for Gastroesophageal Reflux Disease, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. Indonesia GASTROINTESTINAL PRODUCTS Market for Irritable Bowl Syndrome, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. Indonesia GASTROINTESTINAL PRODUCTS Market for Inflammatory Bowel Disease, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. Indonesia GASTROINTESTINAL PRODUCTS Market for Other Disease, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. Indonesia GASTROINTESTINAL PRODUCTS Market for Hospital, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. Indonesia GASTROINTESTINAL PRODUCTS Market for Ambulatory Surgical Center & Independent Surgical Center, Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. Indonesia GASTROINTESTINAL PRODUCTS Market for Clinics, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. Indonesia GASTROINTESTINAL PRODUCTS Market for Other End Users, Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. Indonesia GASTROINTESTINAL PRODUCTS Market for End-user 5, Revenue (USD Million) 2018 – 2032 75

FIG NO. 46. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Technology, 2023 & 2032 77

FIG NO. 47. Market Attractiveness Analysis, By Technology 78

FIG NO. 48. Incremental Revenue Growth Opportunity by Technology, 2024 – 2032 78

FIG NO. 49. GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018, 2023, 2027 & 2032 79

FIG NO. 50. Indonesia GASTROINTESTINAL PRODUCTS Market for Technology 1, Revenue (USD Million) 2018 – 2032 80

FIG NO. 51. Indonesia GASTROINTESTINAL PRODUCTS Market for Technology 2, Revenue (USD Million) 2018 – 2032 81

FIG NO. 52. Indonesia GASTROINTESTINAL PRODUCTS Market for Technology 3, Revenue (USD Million) 2018 – 2032 82

FIG NO. 53. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Distribution Channel, 2023 & 2032 84

FIG NO. 54. Market Attractiveness Analysis, By Distribution Channel 85

FIG NO. 55. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 85

FIG NO. 56. GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 86

FIG NO. 57. Indonesia GASTROINTESTINAL PRODUCTS Market for Distribution Channel 1, Revenue (USD Million) 2018 – 2032 87

FIG NO. 58. Indonesia GASTROINTESTINAL PRODUCTS Market for Distribution Channel 2, Revenue (USD Million) 2018 – 2032 88

FIG NO. 59. Indonesia GASTROINTESTINAL PRODUCTS Market for Distribution Channel 3, Revenue (USD Million) 2018 – 2032 89

FIG NO. 60. Indonesia GASTROINTESTINAL PRODUCTS Market for Distribution Channel 4, Revenue (USD Million) 2018 – 2032 90

FIG NO. 61. Indonesia GASTROINTESTINAL PRODUCTS Market for Distribution Channel 5, Revenue (USD Million) 2018 – 2032 91

FIG NO. 62. Research Methodology – Detailed View 100

FIG NO. 63. Research Methodology 101

List of Tables

TABLE NO. 1. : Indonesia GASTROINTESTINAL PRODUCTS Market: Snapshot 18

TABLE NO. 2. : Drivers for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 22

TABLE NO. 3. : Restraints for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 24

TABLE NO. 4. : Indonesia GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 34

TABLE NO. 5. : Key Raw Materials & Suppliers 35

TABLE NO. 6. : Indonesia GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 (USD Million) 89

TABLE NO. 7. : Indonesia GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2024 – 2032 (USD Million) 89

TABLE NO. 8. : Indonesia GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018 – 2023 (USD Million) 90

TABLE NO. 9. : Indonesia GASTRO

INTESTINAL PRODUCTS Market Revenue, By Indications, 2024 – 2032 (USD Million) 90

TABLE NO. 10. : Indonesia GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018 – 2023 (USD Million) 91

TABLE NO. 11. : Indonesia GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2024 – 2032 (USD Million) 91

TABLE NO. 12. : Indonesia GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018 – 2023 (USD Million) 92

TABLE NO. 13. : Indonesia GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2024 – 2032 (USD Million) 92

TABLE NO. 14. : Indonesia GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 93

TABLE NO. 15. : Indonesia GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 93

Frequently Asked Questions

What is the current size of the Indonesia Gastrointestinal Products market?

The Indonesia Gastrointestinal Products market is valued at USD 84.46 million in 2023 and is projected to grow to USD 137.08 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.51%.

What factors are driving the growth of the Indonesia Gastrointestinal Products market?

The market’s growth is driven by the increasing prevalence of gastrointestinal disorders, such as GERD, IBS, and IBD, as well as rising healthcare awareness and expanding access to medical services. Additional factors include advancements in medical technologies, a growing aging population, and the adoption of over-the-counter (OTC) gastrointestinal products.

What are the key segments within the Indonesia Gastrointestinal Products market?

Key segments include:
• By Devices: Endoscopy Devices, Ablation Devices, Motility Testing Devices, Biopsy Devices, and Stenting Devices.
• By Indications: Gastrointestinal Cancers, Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Other Diseases.
• By End-User: Hospitals, Ambulatory Surgical Centers, Clinics, and Other End Users.
• By Geography: Java, Sumatra, Kalimantan, and Sulawesi.

What are some challenges faced by the Indonesia Gastrointestinal Products market?

Challenges include navigating complex regulatory frameworks, the high cost of advanced gastrointestinal devices, and price sensitivity among consumers. These factors can hinder the affordability and accessibility of innovative gastrointestinal products, particularly in rural and underserved regions.

Who are the major players in the Indonesia Gastrointestinal Products market?

Key players include Boston Scientific Corporation, Medtronic, Stryker, Karl Storz, and Pentax Medical. These companies are recognized for their innovation in diagnostic and therapeutic gastrointestinal devices, while local players also contribute to market growth with cost-effective solutions and strong distribution networks.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –